$RGC quick chart analysis. Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Watching this as it chops around still rising 40 weekly small moving average on light volume. Accumulation day on Friday 07/29. Seeing 89.1% insider owned, little to no shares short.